首页|实体瘤脑膜转移鞘内药物治疗进展

实体瘤脑膜转移鞘内药物治疗进展

扫码查看
实体瘤脑膜转移是肿瘤晚期一种灾难性的合并症,预后很差,目前缺乏有效的治疗方法.鞘内化疗作为脑膜转移癌治疗的一种方法,虽然得到了许多指南或者专家共识的推荐,在临床实践中也经常应用,但鞘内化疗的疗效一直缺乏高质量研究证据的支持.甲氨蝶呤、阿糖胞苷、塞替派等鞘内化疗常用的药物疗效并不理想.本文对新型鞘内注射药物的用法、疗效和安全性进行总结.
Progress in intrathecal therapy for solid tumor meningeal metastasis
Solid tumor meningeal metastasis is a catastrophic complication in the late stage of tumors,with a poor prognosis and currently lacking effective treatment methods.As a treatment method for meningeal metastasis,intrathecal chemotherapy has been recommended by many guidelines or expert consensus,and is often used in clinical practice.However,the efficacy of intrathecal chemotherapy has always lacked high-quality research evidence to support it.The efficacy of commonly used intrathecal chemotherapy drugs such as methotrexate,cytarabine,and thiotepa is not ideal.This article summarizes the usage,efficacy,and safety of new intrathecal injection drugs.

Meningeal metastasisIntrathecal chemotherapy

詹琼、梁晓华

展开 >

复旦大学附属华山医院肿瘤科,上海 200400

脑膜转移 鞘内化疗

2024

肿瘤
上海市肿瘤研究所

肿瘤

CSTPCD
影响因子:1.112
ISSN:1000-7431
年,卷(期):2024.44(1)
  • 45